These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 29855512)

  • 1. A novel oral camptothecin analog, gimatecan, exhibits superior antitumor efficacy than irinotecan toward esophageal squamous cell carcinoma in vitro and in vivo.
    Zou J; Li S; Chen Z; Lu Z; Gao J; Zou J; Lin X; Li Y; Zhang C; Shen L
    Cell Death Dis; 2018 May; 9(6):661. PubMed ID: 29855512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gimatecan exerts potent antitumor activity against gastric cancer in vitro and in vivo via AKT and MAPK signaling pathways.
    Chen Z; Liu Z; Huang W; Li Z; Zou J; Wang J; Lin X; Li B; Chen D; Hu Y; Ji J; Gao J; Shen L
    J Transl Med; 2017 Dec; 15(1):253. PubMed ID: 29237470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular basis of antiproliferative and antitumor activity of the novel camptothecin derivative, gimatecan, in bladder carcinoma models.
    Ulivi P; Zoli W; Fabbri F; Brigliadori G; Ricotti L; Tesei A; Rosetti M; De Cesare M; Beretta GL; Corna E; Supino R; Zunino F
    Neoplasia; 2005 Feb; 7(2):152-61. PubMed ID: 15802020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of drug efflux proteins and topoisomerase I mutations on the camptothecin analogue gimatecan.
    Gounder MK; Nazar AS; Saleem A; Pungaliya P; Kulkarni D; Versace R; Rubin EH
    Invest New Drugs; 2008 Jun; 26(3):205-13. PubMed ID: 17943230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Camptothecin Derivative 3j Inhibits Nsclc Proliferation Via Induction of Cell Cycle Arrest By Topo I-Mediated DNA Damage.
    Liu Y; Zhang J; Feng S; Zhao T; Li Z; Wang L; Wang P; Du H; Yuan S; Sun L
    Anticancer Agents Med Chem; 2019; 19(3):365-374. PubMed ID: 30523769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-Phycocyanin elicited antitumor efficacy via cell-cycle arrest, apoptosis induction, and invasion inhibition in esophageal squamous cell carcinoma.
    Zhang X; Fan T; Li S; Guan F; Zhang J; Liu H
    J Recept Signal Transduct Res; 2019 Apr; 39(2):114-121. PubMed ID: 31322033
    [No Abstract]   [Full Text] [Related]  

  • 7. Chimmitecan, a novel 9-substituted camptothecin, with improved anticancer pharmacologic profiles in vitro and in vivo.
    Huang M; Gao H; Chen Y; Zhu H; Cai Y; Zhang X; Miao Z; Jiang H; Zhang J; Shen H; Lin L; Lu W; Ding J
    Clin Cancer Res; 2007 Feb; 13(4):1298-307. PubMed ID: 17287296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rabdocoestin B exhibits antitumor activity by inducing G2/M phase arrest and apoptosis in esophageal squamous cell carcinoma.
    Wang J; Zhang Z; Che Y; Yuan Z; Lu Z; Li Y; Wan J; Sun H; Chen Z; Pu J; He J
    Cancer Chemother Pharmacol; 2018 Mar; 81(3):469-481. PubMed ID: 29308536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gimatecan and other camptothecin derivatives poison Leishmania DNA-topoisomerase IB leading to a strong leishmanicidal effect.
    Prada CF; Alvarez-Velilla R; Balaña-Fouce R; Prieto C; Calvo-Álvarez E; Escudero-Martínez JM; Requena JM; Ordóñez C; Desideri A; Pérez-Pertejo Y; Reguera RM
    Biochem Pharmacol; 2013 May; 85(10):1433-40. PubMed ID: 23466420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel camptothecin derivative, ZBH-01, exhibits superior antitumor efficacy than irinotecan by regulating the cell cycle.
    Li Y; Zhao D; Zhang W; Yang M; Wu Z; Shi W; Lan S; Guo Z; Yu H; Wu D
    J Transl Med; 2023 Jun; 21(1):422. PubMed ID: 37386467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel lipophilic camptothecin analogue gimatecan is very active in vitro in human neuroblastoma: a comparative study with SN38 and topotecan.
    Di Francesco AM; Riccardi A; Barone G; Rutella S; Meco D; Frapolli R; Zucchetti M; D'Incalci M; Pisano C; Carminati P; Riccardi R
    Biochem Pharmacol; 2005 Oct; 70(8):1125-36. PubMed ID: 16139802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest.
    Wang J; Li Q; Yuan J; Wang J; Chen Z; Liu Z; Li Z; Lai Y; Gao J; Shen L
    J Transl Med; 2017 Jun; 15(1):127. PubMed ID: 28578693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumour effects of artesunate via cell cycle checkpoint controls in human oesophageal squamous carcinoma cells.
    Mao L; Deng G; Li M; Lu SH; Jiang W; Yu X
    Eur J Med Res; 2024 May; 29(1):293. PubMed ID: 38773551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular bases of the antitumor activity of a 7-substituted camptothecin in hormone-refractory human prostate carcinoma models.
    Zuco V; Supino R; De Cesare M; Carenini N; Perego P; Gatti L; Pratesi G; Pisano C; Martinelli R; Bucci F; Zanier R; Carminati P; Zunino F
    Biochem Pharmacol; 2003 Apr; 65(8):1281-94. PubMed ID: 12694869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corilagin Inhibits Esophageal Squamous Cell Carcinoma by Inducing DNA Damage and Down-Regulation of RNF8.
    Qiu F; Liu L; Lin Y; Yang Z; Qiu F
    Anticancer Agents Med Chem; 2019; 19(8):1021-1028. PubMed ID: 30848215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two novel camptothecin derivatives inhibit colorectal cancer proliferation via induction of cell cycle arrest and apoptosis in vitro and in vivo.
    Du H; Huang Y; Hou X; Quan X; Jiang J; Wei X; Liu Y; Li H; Wang P; Zhan M; Ai X; Lu L; Yuan S; Sun L
    Eur J Pharm Sci; 2018 Oct; 123():546-559. PubMed ID: 30118848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Efficacy of Intravenous Gimatecan on Human Tumor Xenografts.
    DE Cesare M
    Anticancer Res; 2018 Oct; 38(10):5783-5790. PubMed ID: 30275200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetyl-macrocalin B suppresses tumor growth in esophageal squamous cell carcinoma and exhibits synergistic anti-cancer effects with the Chk1/2 inhibitor AZD7762.
    Wang JN; Che Y; Yuan ZY; Lu ZL; Li Y; Zhang ZR; Li N; Li RD; Wan J; Sun HD; Sun N; Puno PT; He J
    Toxicol Appl Pharmacol; 2019 Feb; 365():71-83. PubMed ID: 30633885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effects with apoptotic death in human promyelocytic leukemia HL-60 cells and suppression of leukemia xenograft tumor growth by irinotecan HCl.
    Chen YL; Chueh FS; Yang JS; Hsueh SC; Lu CC; Chiang JH; Lee CS; Lu HF; Chung JG
    Environ Toxicol; 2015 Jul; 30(7):803-15. PubMed ID: 24474168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer effects of suberoylanilide hydroxamic acid in esophageal squamous cancer cells in vitro and in vivo.
    Tzao C; Jin JS; Chen BH; Chung HY; Chang CC; Hsu TY; Sun GH
    Dis Esophagus; 2014; 27(7):693-702. PubMed ID: 24033428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.